drenbio.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Dren |
| Description | Dren Bio Home Team Platform Pipeline Careers News Contact Latest News --> Engaging relevant elements of the immune system to eradicate disease Dren Bio Home Dre |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 107.180.3.128 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
drenbio.com Valuation
|
US$7,945,017
Last updated: 2023-05-07 14:25:52
drenbio.com has Semrush global rank of 1,332,194. drenbio.com has an estimated worth of US$ 7,945,017, based on its estimated Ads revenue. drenbio.com receives approximately 916,733 unique visitors each day. Its web server is located in United States, with IP address 107.180.3.128. According to SiteAdvisor, drenbio.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$7,945,017 |
| Daily Ads Revenue | US$7,334 |
| Monthly Ads Revenue | US$220,016 |
| Yearly Ads Revenue | US$2,640,191 |
| Daily Unique Visitors | 61,116 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| drenbio.com. | A | 7199 | IP: 107.180.3.128 |
| drenbio.com. | NS | 3600 | NS Record: ns71.domaincontrol.com. |
| drenbio.com. | NS | 3600 | NS Record: ns72.domaincontrol.com. |
| drenbio.com. | MX | 3600 | MX Record: 0 drenbio-com.mail.protection.outlook.com. |
| drenbio.com. | TXT | 1800 | TXT Record: v=spf1 a mx ip4:107.128.101.113 include:spf.protection.outlook.com include:secureserver.net ~all |
HtmlToTextCheckTime:2023-05-07 14:25:52
| Home Team Platform Pipeline Careers News Contact Latest News --> Engaging relevant elements of the immune system to eradicate disease Dren Bio Home Dren Bio is a privately held, biopharmaceutical company focused on developing therapeutic antibodies for the treatment of cancer, autoimmune and other serious diseases. The Company’s management team and scientific advisors have significant expertise covering the discovery and development of engineered antibodies designed to selectively target and deplete pathologic cells, protein aggregates and other disease-causing agents. At Dren we selectively engage an effector cell for targeted depletion of diseased cells or agents. Our pipeline is currently comprised of two distinct drug discovery programs. DR-01, the Company’s lead product candidate from its enhanced antibody-dependent cellular cytotoxicity (“ADCC”) program, induces the potent antibody-mediated killing of a cell type that possesses intrinsic cytotoxic potential and is responsible |
HTTP Headers
HTTP/1.1 302 Found Date: Thu, 28 Oct 2021 05:08:18 GMT Server: Apache Location: https://www.drenbio.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 last-modified: Thu, 07 Oct 2021 18:46:10 GMT etag: "7fa00cf-174dc-5cdc7ad223210" accept-ranges: bytes content-length: 95452 vary: Accept-Encoding content-type: text/html date: Thu, 28 Oct 2021 05:08:18 GMT server: Apache |
drenbio.com Whois Information
Domain Name: DRENBIO.COM Registry Domain ID: 2390910545_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-05-10T23:12:22Z Creation Date: 2019-05-14T18:36:02Z Registry Expiry Date: 2026-05-14T18:36:02Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS71.DOMAINCONTROL.COM Name Server: NS72.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T22:49:30Z <<< |